Effects of maternal bisphosphonate use on fetal and neonatal outcomes.
CONCLUSION: A limited body of published data suggests that maternal use of bisphosphonates before or during pregnancy does not have serious fetal or neonatal adverse effects.
PMID: 25404594 [PubMed - in process]
Source: American Journal of Health-System Pharmacy : AJHP - Category: Drugs & Pharmacology Authors: Green SB, Pappas AL Tags: Am J Health Syst Pharm Source Type: research
More News: Actonel | Children | Drugs & Pharmacology | Neurology | Perinatology & Neonatology | Pregnancy | Reclast | Risedronate | Study | Women | Zometa